SEC ownership of Rallybio Corp

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001739410.

Comparable stake leader

ADAR1 Capital Management, LLC

Disclosed value leader

5AM Opportunities I, L.P.

Comparable rows

40/50

Latest evidence

06 Jul 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
40 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
ADAR1 Capital Management, LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
06 Jul 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001739410
Issuer location
New Haven, CT

Ownership snapshot

Top shareholders of Rallybio Corp (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ADAR1 Capital Management,...
Disclosed value leader
5AM Opportunities I, L.P.
Comparable rows
40/50
Latest evidence
06 Jul 2026
13D/G 3/4/5 13F Lead comparable stake: 18% 10 rows are not safely comparable across share classes. 13D/G row: ADAR1 Capital Management, LLC Showing 1-8 of 50 holder rows.

Quick read

ADAR1 Capital Management, LLC leads the comparable SEC ownership view at 18%.

40 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ADAR1 Capital Management, LLC's linked filing trail.
Comparable ownership Top 5
ADAR1 Capital Management, LLC 18%
FMR LLC 11%
VIKING GLOBAL INVESTORS LP 10%
Cormorant Asset Management, LP 7.6%
TPG GP A, LLC 7.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ADAR1 Capital Management, LLC
13D/G 3/4/5 13F
10%+ Owner · Company
18%
$13,293,151
926,352 shares
$0 31 May 2026
FMR LLC
13F 13D/G 3/4/5
Company · Other*, 10%+ Owner
11%
from 13D/G
$7,117,256
793,451 shares
31 Mar 2026
VIKING GLOBAL INVESTORS LP
13F 13D/G 3/4/5
Company · 10%+ Owner
10%
from 13D/G
$4,703,393
524,347 shares
31 Mar 2026
Cormorant Asset Management, LP
13F 13D/G
Company
7.6%
from 13D/G
$3,588,000
400,000 shares
31 Mar 2026
TPG GP A, LLC
13F 13D/G
Company
7.2%
from 13D/G
$3,395,602
378,551 shares
31 Mar 2026
BALYASNY ASSET MANAGEMENT L.P.
13F 13D/G
Company
7.1%
from 13D/G
$3,377,860
376,573 shares
31 Mar 2026
Laurion Capital Management LP
13F 13D/G
Company
5.7%
from 13D/G
$2,715,721
302,756 shares
31 Mar 2026
Nantahala Capital Management, LLC
13F 13D/G
Company
5.7%
from 13D/G
$2,696,696
300,635 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to buying over the last 12 months. Net value: +$8,458,527.

Buys
$8,458,527
Insiders: 2
Sells
$0
Insiders: 0
Net
+$8,458,527
Shares: +604,946
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 604,946 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 604,946 0 $8,458,527 $0 +$8,458,527
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 22 reporting-owner rows connected to Rallybio Corp. Open a relationship link for the CIK-to-CIK filing trail.

Rows
22
Largest Forms 3/4/5 holder
5AM Opportunities I, L.P.
Net 12M change
+$8,458,526
Latest report
06 Jul 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
5AM Opportunities I, L.P. 10%+ Owner $30,591,937 Mixed 03 Jun 2022
5AM Partners V, LLC 10%+ Owner $29,771,937 Mixed 07 Mar 2023
5AM Ventures V, L.P. 10%+ Owner $22,833,933 Mixed 29 Jul 2021
ADAR1 Capital Management, LLC 10%+ Owner $12,783,657 +$4,229,263 +49% Filing P/S 18 May 2026
Daniel Schneeberger 10%+ Owner $12,783,657 +$4,229,263 +49% Filing P/S 18 May 2026
Jeffrey M. Fryer Chief Financial Officer & Treasurer $385,794 Mixed 21 Mar 2022
Stephen Uden Chief Executive Officer, Director $317,590 Mixed 14 Feb 2025
Steven Ryder Chief Medical Officer $126,000 Mixed 14 Feb 2025
FMR LLC Other*, 10%+ Owner $122,842 Market 04 Mar 2026
Helen M. Boudreau Director $87,886 Mixed 06 Jul 2026
Robert Lorne Hopfner Director $80,705 Mixed 13 May 2025
Hui Liu Director $76,705 Mixed 13 May 2025
Martin Mackay Director $64,998 Mixed 18 Feb 2026
Ronald Hunt Director $51,498 Mixed 18 Feb 2026
Wendy Chung Director $29,205 Mixed 13 May 2025
Kush Parmar Director $29,205 Mixed 15 May 2024
Paula Soteropoulos Director $29,205 Mixed 13 May 2025
Christine A. Nash Director $29,205 Mixed 13 May 2025
Timothy M. Shannon Director $10,693 Mixed 03 Jan 2022
Jonathan I. Lieber Chief Financial Officer $2,823 Mixed 18 Feb 2026

Recent insider transactions for Rallybio Corp

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Helen M. Boudreau RLYB Common Stock Options Exercise 119.5% 3,562 6,542 06 Jul 2026 Direct
Helen M. Boudreau RLYB Option (Right to Buy) Options Exercise -100% -3,562 0 06 Jul 2026 Direct
ADAR1 Capital Management, LLC RLYB Common Stock Purchase 1.11% $142,582 $13.98 10,200 926,352 19 May 2026 See Footnote
ADAR1 Capital Management, LLC RLYB Common Stock Purchase 1.11% $142,582 $13.98 10,200 926,352 19 May 2026 See Footnote
ADAR1 Capital Management, LLC RLYB Common Stock Purchase 0.66% $83,981 $13.98 6,009 916,152 18 May 2026 See Footnote
ADAR1 Capital Management, LLC RLYB Common Stock Purchase 0.66% $83,981 $13.98 6,009 916,152 18 May 2026 See Footnote
ADAR1 Capital Management, LLC RLYB Common Stock Purchase 0.03% $4,170 $13.90 300 910,143 15 May 2026 See Footnote
ADAR1 Capital Management, LLC RLYB Common Stock Purchase 0.03% $4,170 $13.90 300 910,143 15 May 2026 See Footnote
ADAR1 Capital Management, LLC RLYB Common Stock Purchase 9.54% $1,108,807 $13.99 79,259 909,843 13 May 2026 See Footnote
ADAR1 Capital Management, LLC RLYB Common Stock Purchase 9.54% $1,108,807 $13.99 79,259 909,843 13 May 2026 See Footnote
ADAR1 Capital Management, LLC RLYB Common Stock Purchase 0.1% $11,063 $13.83 800 830,584 12 May 2026 See Footnote
ADAR1 Capital Management, LLC RLYB Common Stock Purchase 0.1% $11,063 $13.83 800 830,584 12 May 2026 See Footnote
ADAR1 Capital Management, LLC RLYB Common Stock Purchase 6.41% $699,992 $14.00 50,000 829,784 11 May 2026 See Footnote
ADAR1 Capital Management, LLC RLYB Common Stock Purchase 6.41% $699,992 $14.00 50,000 829,784 11 May 2026 See Footnote
ADAR1 Capital Management, LLC RLYB Common Stock Purchase 4.71% $491,260 $14.00 35,101 779,784 05 May 2026 See Footnote
ADAR1 Capital Management, LLC RLYB Common Stock Purchase 4.71% $491,260 $14.00 35,101 779,784 05 May 2026 See Footnote
ADAR1 Capital Management, LLC RLYB Common Stock Purchase 19.4% $1,687,409 $13.97 120,804 744,683 04 May 2026 See Footnote
ADAR1 Capital Management, LLC RLYB Common Stock Purchase 19.4% $1,687,409 $13.97 120,804 744,683 04 May 2026 See Footnote
Jonathan I. Lieber RLYB Common Stock Sale -16.1% -789 4,115 23 Feb 2026 Direct
Jonathan I. Lieber RLYB Common Stock Award 104% 2,500 4,904 18 Feb 2026 Direct
Martin Mackay RLYB Option (Right to Buy) Award 18,055 18,055 18 Feb 2026 Direct
Ronald Hunt RLYB Option (Right to Buy) Award 14,305 14,305 18 Feb 2026 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .